Danaher (DHR) EBT Growth (1y) (2010 - 2026)
Danaher (DHR) EBT Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 12.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 64.58% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 15.14% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 56.92% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.81% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -27.03% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -15.03% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 16.39% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 7.29% |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 16.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | 64.58% |
| Mar 27, 2026 | 9.39% |
| Dec 31, 2025 | 4.41% |
| Sep 26, 2025 | 10.13% |
| Jun 27, 2025 | -39.52% |
| Mar 28, 2025 | -11.17% |
| Dec 31, 2024 | 6.74% |
| Sep 27, 2024 | -14.82% |
| Jun 28, 2024 | -5.17% |
| Mar 29, 2024 | -16.55% |
| Dec 31, 2023 | 17.67% |
| Sep 29, 2023 | -40.60% |
| Jun 30, 2023 | -44.80% |
| Mar 31, 2023 | -27.44% |
| Dec 31, 2022 | 4.91% |
| Sep 30, 2022 | 39.22% |
| Jul 1, 2022 | 1.27% |
| Apr 1, 2022 | 0.77% |
| Dec 31, 2021 | -35.28% |
| Oct 1, 2021 | 35.85% |